Global Burden of Heart Failure Attributable to Chronic Kidney Disease from 1990 to 2021 and Future Projections to 2050: A GBD 2021 Study

Scritto il 14/11/2026
da Min-Jia Li

Cardiorenal Med. 2026 Nov 14:abtag021. doi: 10.1159/crm/abtag021. Online ahead of print.

ABSTRACT

BACKGROUND: Heart failure attributable to chronic kidney disease (CKD) represents an important manifestation of the cardiorenal syndrome. However, its global burden, long-term trends, and relative contribution to the overall heart failure burden remain insufficiently characterized.

METHODS: In this observational, GBD-based analysis, data were obtained from the Global Burden of Disease 2021 study. We analyzed prevalence and years lived with disability (YLDs) of heart failure attributable to CKD from 1990 to 2021 at global, socio-demographic index (SDI) quintile, and national levels. Temporal trends were assessed using age-standardized rates, joinpoint regression, and age-period-cohort analysis. The relative contribution of CKD was calculated as CKD-attributable all-age numbers divided by total heart failure numbers. Future YLD rates were projected to 2050 using a Bayesian age-period-cohort model.

RESULTS: Globally, prevalent cases increased from 506,142 in 1990 to 1,543,034 in 2021. The age-standardized prevalence rate rose from 10.44 to 19.14 per 100,000 population, and the age-standardized YLD rate increased from 1.33 to 2.42 per 100,000. The CKD-attributable share of total heart failure prevalence increased from 2.03% to 2.90%, and the corresponding YLD share increased from 2.74% to 3.86%. The projected global YLD rate reached 4.67 per 100,000 by 2050.

CONCLUSIONS: CKD-attributable heart failure increased substantially from 1990 to 2021 and is projected to continue rising. CKD accounted for a small but increasing share of the global heart failure burden, supporting integration of kidney disease detection and management into heart failure prevention strategies.

PMID:43033432 | DOI:10.1159/crm/abtag021